StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MAGADSUGAR.BO$457.75-0.81%
Fair $457.75+0.0%

MAGADSUGAR.BO

MAGADSUGAR.BO

Consumer Defensive / ConfectionersBSE

$457.75

-3.75 (-0.81%)

Fairly Valued+0.0%Fair Value $457.75Fund rank 25/100 · Data gapFallback financials|
SA 40/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-130.4M · quality 38.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 19/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · MAGADSUGAR.BOLocal privado en este navegador · MAGADSUGAR.BO
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$6.5B

P/E

10.2x

↓

EV/EBITDA

8.9x

↓

ROE

7.2%

↑

Gross Margin

27.7%

↑

Debt/Equity

0.79

↑
52-Week Range$458
$413$803

TradingView lightweight chart

MAGADSUGAR.BO price, volumen y niveles de valoración

Último $457.75Periodo +85.3%
Fair value: $457.75

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+9.4%

FCF CAGR

-12.2%

FCF margin

5.0%

FCF / Net income

0.99x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $12.45B · net income $635.1M · FCF $628.4M

2023-FY → 2026-FY

Gross margin

27.7%+1.4% pts

Operating margin

9.4%-1.8% pts

Net margin

5.1%-0.2% pts

FCF margin

5.0%-4.7% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$12.45B$12.45B$13.22B$10.94B$9.50B
Net Income$635.1M$635.1M$1.09B$1.16B$502.6M
EBITDA$1.51B$1.51B$2.14B$2.15B$1.33B
EPS——77.6782.6135.67
Gross Margin27.7%27.7%31.6%32.2%26.3%
Operating Margin9.4%9.4%13.9%17.3%11.3%
Net Margin5.1%5.1%8.3%10.6%5.3%
Balance Sheet
Debt/Equity0.790.790.850.850.91
Current Ratio1.251.25———
Cash Flow
Free Cash Flow$628.4M$628.4M$-130.4M$-165.7M$929.6M
Returns
ROE7.2%7.2%13.1%15.6%7.9%
Valuation
P/E10.2410.248.346.989.61
EV/EBITDA8.878.877.586.758.03
P/B0.730.731.091.090.76
Growth & Yield
Revenue Growth-5.9%-5.9%20.8%15.2%—
EPS Growth——-6.0%131.6%—
Dividend Yield2.7%2.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -33.9%

Total return

-33.9%

Start / end P/E

n/dx → n/dx

EPS bridge

77.67 → n/d

Residual

-36.6%

EPS growthn/d
Multiple reratingn/d
Dividend+2.7%
Residual / FX / buybacks / cross-term-36.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.